|
|
|
American Society of Interventional Pain Physicians News | September 23, 2015
|
|
|
 Scientific American PAIN MANAGEMENT with ASIPP Online Learning System
Decker Intellectual Properties Inc has signed a branding agreement with the American Society of Interventional Pain Physicians (ASIPP) to establish the comprehensive professional surgical online-learning database, Scientific American PAIN MANAGEMENT with ASIPP (SAPM). The subscription-based database, to launch in 2016, will be an inclusive, continuously updated modular resource for anesthesiologists, neurologists and other physicians in training and practice.
Decker is renowned for providing practicing clinicians and students with comprehensive and up-to-date medical and surgical information through Scientific American Medicine and Scientific American Surgery. The new database will utilize the platform and unique educational features of these iconic publications to establish the new offering to physicians involved in the management of pain.
The module content for the SAPM resource will be based upon the new training curriculum used for the American Board of Anesthesiology, the American Board of Physical Medicine and Rehabilitation, the American Board of Psychiatry and Neurology, American Board of Emergency Medicine, American Board of Family Medicine, American Board of Radiology, and the American Board of Interventional Pain Physicians Exams in Pain Management. ASIPP has played an instrumental role in the development and refinement of the curriculum
Becker's newsletter published the following about this:
|
Registration for ASIPP's November meetings is open
| BROCHURE | HOTEL | ONLINE REGISTRATION|
Regenerative medicine is a new and evolving field for interventional pain management. Know if and when to offer these treatments.
Choose to attend one of ASIPP's November meetings. You can attend the 2-day intensive Regenerative Medicine Workshop or the 1 day Hands-On Cadaver Workshop for IPM Techniques.
Objectives for Regenerative Medicine Course
- Attain understanding of regenerative medicine.
- Attain eligibility for competency certification with the completion of both levels.
- Incorporate regenerative medicine in treating your patients so that patients have better outcomes and reduced side effects.
- Provide high-quality, competent, safe, accessible, and cost-efficient services to your patients.
Objectives for Cadaver Workshop for IPM Techniques
- Integrate multiple aspects of interventional pain management in treating your patients so that patients have better outcomes and reduced side effects.
- Provide high-quality, competent, safe, accessible, and cost-efficient services to your patients.
- Improve existing skills and/or develop new skills in the delivery of interventional techniques.
- Review multiple areas of interventional pain management including fluoroscopic interpretation
 Accommodations
THE VENETIAN RESORT HOTEL CASINO
3355 Las Vegas Blvd. South, Las Vegas, NV 89109
Hotel: 702.414.1000 | Reservations: 866.659.9643
http://www.venetian.com
Inform the agent that you are booking for American Society of Interventional Pain Physicians. We have secured a group rate of $159. Register early, as all unbooked rooms will be released on October 29, 2015 or until sold out, whichever occurs first.
Cadaver Venue:
OQUENDO
CENTER
, 2425 E. Oquendo Road, Las Vegas, NV 89120
Phone: 702.739.6698 | Toll Free: 866.800.7326 |
|
Flipping the code switch: Healthcare industry nervous about readiness for big ICD-10-CM conversion
 Ready or not, the U.S. healthcare industry is poised to flip the switch from the ICD-9 to the ICD-10 diagnostic and procedural coding system on Oct. 1, significantly changing how billions of dollars in medical claims are calculated and billed every day.
Experts predict most large hospitals and health systems and most large physician groups will weather the federally required conversion just fine, though they could experience temporary cash-flow squeezes because of ICD-10-related payment delays.
The organizations most likely to have trouble, however, are smaller providers, particularly smaller physician practices. Some medical groups say problems associated with the conversion could drive some small doctor groups out of business.
|
Pain Physician Publishes Health Policy Review: Survival Strategies for Tsunami of ICD-10-CM for Interventionalists: Pursue or Perish!
Members of ASIPP have published survival strategies in this issue of Pain Physician. Since ICD-10-CM will be effective October 1, 2015, each and every physician has to be prepared. Consequently, we are providing you with the tables to assist you with the conversion.
Many of you have electronic medical records which you are hoping will convert automatically. As you see in this manuscript and also the codes converted, this will not be the case.
It is crucial that each condition be re-coded for accuracy and to avoid denials and subsequent cash crunch.
A single comprehensive table shows the conversion of commonly used spinal codes summarized into 2 pages. This can be carried on and put in the chart, even along with the other tables with modifications. You may not need to continue to use ICD-9 codes, however they are provided for your reference.
We have created 3 tables showing cervical, thoracic, and lumbosacral coding subsequently there are multiple tables with conversion of RSD, causalgia, and neuropathy, headache and facial neuralgia, upper extremity joint coding, lower extremity joint coding, psychological coding, and drug abuse coding.
Abstract
The unfunded mandate for the implementation of International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is scheduled October 1, 2015. The development of ICD-10-CM has been a complicated process. We have endeavored to keep Interventional Pain Management doctors apprised via a variety of related topical manuscripts. The major issues relate to the lack of formal physician participation in its preparation. While the American Health Information Management Association (AHIMA) and American Hospital Association (AHA) as active partners in its preparation. Centers for Medicare and Medicaid Services (CMS) and Centers for Disease Control and Prevention (CDC) are major players; 3M and Blue Cross Blue Shield Association are also involved.
The cost of ICD-10-CM implementation is high, similar to the implementation of electronic health records (EHRs), likely consuming substantial resources. While ICD-10, utilized worldwide, includes 14,400 different codes, ICD-10-CM, specific for the United States, has expanded to 144,000 codes, which also includes procedural coding system.
It is imperative for physicians to prepare for the mandatory implementation. Conversion from ICD-9-CM to ICD-10-CM coding in interventional pain management is not a conversion of one to one that can be easily obtained from software packages. It is a both a difficult and time-consuming task with each physician, early on, expected to spend on estimation at least 10 minutes per visit on extra coding for established and new patients. For interventional pain physicians, there have been a multitude of changes, including creation of new codes and confusing conversion of existing codes.
This manuscript describes a variety of codes that are relevant to interventional pain physicians and often utilized in daily practices. It is our objective that this manuscript will provide coding assistance to interventional pain physicians.
|
Make your plans now to participate in the American Society of Interventional Pain Physicians abstract and poster presentation at the 18th Annual Meeting, April 15-17 in Dallas, Texas.
We had tremendous success last year with our electronomic poster presentation area and we plan to continue this again for the 18th annual meeting.The top 20 posters will be selected to participate in the electronic poster presentations with Q & A time with poster presenters. These will also be published in Pain Physician journal. In addition the Top 8 posters will be presented for judging during Friday's session. The top three abstracts will receive cash prizes.
Posters will be on display during the meeting on both Thursday and Friday in the exhibitor hall.
The abstract submission deadline will be February 9, 2016.
The annual meeting is a great opportunity to share your abstract with hundreds of physicians who specialize in interventional pain management.
|
Is Neuropathic Pain a Common Factor in Rheumatoid Arthritis?
Rheumatoid arthritis (RA) is a painful condition on its own thanks to the chronic inflammation of joints in the hands and feet. Despite the help of medication to control inflammation, many RA patients still report experiencing neuropathic pain - even while in remission.
Researchers from the University of Twente in the Netherlands used the painDETECT screening tool to evaluate neuropathic-like pain symptoms in 159 patients (mean age = 57.2 years) with RA, 74.8% of whom were in remission, and 13.2% had low disease activity. Among the patients, about 44% reported clinically-significant pain in the past four weeks, with an average pain score of ≥4 on the 10-point painDETECT scale.
|
ASIPP to Publish Monthly Podcast
 ASIPP will soon be publishing a monthly podcast! Podcasts are becoming more and more popular. You can listen to a podcast on your computer or download it onto your iPod or other MP3 player. The ASIPP podcast will feature news about upcoming ASIPP meetings and didactic courses as well as general medical news and news of interest to interventional pain physicians. Each episode will also have one or more interviews.
The premiere episode will have an interview with Devi Nampiaparimpil, MD. Dr. Devi is an ASIPP board member and published author. She has made numerous national television appearances and will have tips on how to use media to promote your practice. The podcasts will be produced and hosted by ASIPP staff member and sponsor relations coordinator Tom Prigge. The podcasts will be available on the ASIPP Web site.
|
NIH puts blood pressure study results on fast track
The National Institutes of Health last week reported that initial results from a new study indicate that lowering blood pressure rates to a systolic rate of 120 reduces rates of heart attack, heart failure and stroke by nearly a third, and drops mortality rates by almost 25%, compared with a systolic rate of 140.
Those results are part of a 9,300-participant study known as the Systolic Blood Pressure Intervention Trial, known as SPRINT.
The NIH said the results were being disseminated months earlier than planned because of their potential impact.
|
Medical Marijuana Laws and Increasing Adolescent Use: Is There a Link?
We know that marijuana is dangerous for an adolescent's developing brain. We know that 23 states and the District of Columbia have medical marijuana laws. We also know that adolescent use of marijuana continues to go up even while use of other drugs among this age group is leveling off or declining.
Studies show that marijuana use in adolescents is higher in states that have legalized medical marijuana, so it stands to reason that legalizing medical marijuana could increase adolescent marijuana use.1,2 However, sometimes reason does not match the scientific evidence. A review of adolescent marijuana use in more than 1 million adolescents surveyed over 24 years across 48 states provided definitive evidence that legalizing medical marijuana does not increase use among adolescents. The study was published in The Lancet.1,2
|
Study: Painkiller Abuse Higher in Rural vs. Urban Areas
Abuse of prescription painkillers was more likely to occur among adolescents who live in rural areas and small towns vs. adolescents who live in large urban areas, a new study has found. Findings from the study are published in the Journal of Rural Health.
Researchers from Penn State University analyzed data from the 2011 and 2012 National Survey on Drug Use and Health that included 32,036 adolescents on past year prescription and opioid misuse. Specifically, they found that adolescents who live in small cities have a 21% higher chance of abusing prescription painkillers than their peers in large urban areas. These adolescents were also more likely to go to emergency rooms for care than to a primary care practitioner; emergency room clinicians are more likely to prescribe painkillers. They also found that females were more likely to abuse prescription painkillers than males.
|
FDA Investigating Off-Label Pain Med Use in Pediatric Patients
 The Food and Drug Administration (FDA) announced that it is currently investigating the use of tramadol in children aged ≤17 due to a rare but potentially serious risk of slowed or difficult breathing, particularly in children treated with this medication after surgery to remove tonsils and/or adenoids.
Although the opioid analgesic tramadol is not currently FDA-approved for use in children, data show that it is being used "off-label" in pediatric patients. Some patients may have genetic variations that cause the drug to be converted to the active form of the opioid (O-desmethyltramadol) faster and more completely than usual. These ultra-rapid metabolizer patient are more likely to have higher-than-normal amounts of the active form of the opioid in their blood after taking tramadol, which can result in breathing difficulty that may lead to death. A 5-year-old child in France recently experienced severely slowed and difficult breathing requiring emergency intervention and hospitalization after taking a single prescribed dose of tramadol oral solution for pain relief following surgery to remove his tonsils and adenoids; the child was later found to be an ultra-rapid metabolizer and had high levels of O-desmethyltramadol in his body.
|
Turing to Cut Price of Drug Daraprim After Increase Sparks Outcry
A small pharmaceutical company that has come under fire for a more than 50-fold hike in the price of a drug used to fight a parasitic infection will cut the price, though it is still working out by how much, according to a person familiar with the matter.
The drug, Daraprim, had cost $13.50 a tablet before Turing Pharmaceuticals AG bought the U.S. rights in August from Impax Laboratories Inc.IPXL0.17%and raised the price to $750. The increase became a poster child for high drug prices, which have been attacked by drug-benefit managers and some Democrats.
|
|
|
|
|
State Society News
CASIPP Meeting set for October 16-18
The California chapter of the American Society of Interventional Pain Physicians
will hold its 6th Annual Meeting in Monterey, CA at the Monterey Plaza Hotel Resort over the weekend of October 16-18. Agenda and registration can be found online at
www.casipp.com
or by calling 661-435-3473.
NY and NJ Societies to hold Pain Symposium Nov. 5-8
The New York and New Jersey Societies of Interventional Pain Physicians will host a Pain Symposium titled Evolving Pain Therapies on November 5-8, 2015 at the Hyatt Regency, Jersey City, NJ. Click HERE for Schedule and more information.
SAVE the DATE: FSIPP Meeting May 20-22, 2016
The Florida Society of Interventional Pain Physicians will hold its annual meeting in 2016 on May 20-22. The meeting will be held at the Orlando World Center Marriott in Orlando.
Watch FSIPP.org for more details.
|
|
Physicians Wanted To view or post a job, please go to: http://jobs.asipp.org/home To receive a member discount for posting a job, use member code: 20Member |
|
|
